# Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

> **NCT00765921** · PHASE1 · COMPLETED · sponsor: **Massachusetts Eye and Ear Infirmary** · enrollment: 40 (actual)

## Conditions studied

- Choroidal Melanoma

## Interventions

- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT00765921
- **Lead sponsor:** Massachusetts Eye and Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2016-02
- **Final completion:** 2016-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00765921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00765921, "Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00765921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*